• 제목/요약/키워드: Jakyak

검색결과 24건 처리시간 0.021초

Effects of the Geijibokryunghwan on Carrageenan-induced Inflammation and COX-2 in Hepatoma Cells

  • Joo, Shin-Tak;Ban, Chang-Gyu;Park, Soon-Gi;Park, Won-Hwan
    • 동의생리병리학회지
    • /
    • 제20권4호
    • /
    • pp.1027-1031
    • /
    • 2006
  • In oriental medicine, Geijibokryunghwan(GBH) was used to improvement various symptoms created by the thrombosis. We investigated the effects of an oriental medicinal prescriptions, Geijibokryunghwan (GBH) consisting of herbs of Cinnamomi Ramufus (Geiji; 桂枝), Poria cocos (Bokrung; 茯?), Moutan Cortex Radicis(Modanpi; 牧丹皮), Paeoniae Radix (Jakyak; 芍藥) and Persicae Semen (Doin; 桃仁) on tumor growth-inhibitory activity and cancer chempreventive activity in assays representing three maior stages of carcinogenesis. Cancer chempreventive agents include nonsteroidal anti-inflammatory drugs (NSAIDS) such as indomethacin, aspirin, piroxicam, and sulindac, all of which inhibit cyclooxygenase (COX). Effects of the GBH extracts on carrageenan-induced edema Inflammation using female (C57BL/6XC3H) Fl (B6C3Fl ) mice and tumorigenesis were examined. Finally, cyclooxygenase metabolites were determined after extracts treatment. These data suggest that GBH extracts merits investigation as a potential cancer chempreventive agent in humans.

작약, 감초 및 작약감초탕의 투여가 궤양성 대장염 동물 모델에 미치는 영향: 대사산물 변화를 포함하여 (Effects of Paeoniae Radix, Glycyrrhiza Uralensis and Jakyakgamcho-tang Treatment on Ulcerative Colitis Animal Model: Including Changes in Metabolites)

  • 최선희;박은정
    • 대한한방소아과학회지
    • /
    • 제36권3호
    • /
    • pp.19-34
    • /
    • 2022
  • Objectives To investigate the effect of Jakyakgamcho-tang (JGT) on Dextran sulfate sodium (DSS) induced ulcerative colitis. Methods Experimental animals were divided into six groups; group 1, normal group; group 2, DSS-induced colitis group; group 3, 5-aminosalicylic acid (5-ASA)-treated group; group 4, Glycyrrhiza Uralensis (Gamcho, GC)-treated group; group 5, Paeoniae Radix (Jakyak, JY)-treated group; group 6, JGT-treated group. Inflammatory cytokines and their metabolites were detected. Result In the JGT group, the levels of tumor necrosis factor alpha (TNF-α), prostaglandin E2 (PGE2) were significantly decreased, whereas that of Interleukin-10 (IL-10) were significantly increased. In addition, the metabolite profile changed in the JGT group with most metabolites increasing. Conclusion This study demonstrates that the therapeutic potential of JGT in ulcerative colitis. Further studies should be conducted to confirm our findings.

Single-Dose Intramuscular Toxicity Test Using No-Pain Pharmacopuncture in Sprague-Dawley Rats

  • Ji Hye Hwang;Chul Jung
    • 대한약침학회지
    • /
    • 제26권1호
    • /
    • pp.86-93
    • /
    • 2023
  • Objectives: This study aimed to evaluate the potential toxicity of a recently developed and clinically used No-Pain pharmacopuncture (NPP) solution. We also assessed the lethal dose of the NPP agent following a single intramuscular injection in Sprague-Dawley (SD) rats. Methods: Animals were divided into two groups: the NPP test material group and the normal saline control group. A single intramuscular injection of the NPP agent (1.0 mL/animal) was administered to rats of the NPP test material group. The control group rats received the same volume of normal saline. Both female and male rats were included in each group. All rats were monitored for clinical signs and body weight changes for 14 days after administration of the test substance or saline. At the end of the observation period, a gross necropsy was conducted and localized tolerance at the injection site was analyzed. Results: No mortality was observed in the NPP test material and control groups. Moreover, no test substance-related effects were observed on clinical signs, body weight, necropsy findings, and localized tolerance at the injection site. Conclusion: The approximate lethal dose of the NPP agent is greater than 1.0 mL/animal under the conditions used in this study. Additional toxicity evaluations and clinical studies are needed to confirm the safety of NPP use in clinical practice.

鼻疾患의 治療方劑에 對한 文獻的 考察 (The Literature Study on the Herb Treatment of Rhinopathy)

  • 손동석;이태헌;김윤범
    • 한방안이비인후피부과학회지
    • /
    • 제14권1호
    • /
    • pp.11-31
    • /
    • 2001
  • 1. Rhinocleisis: In the frequency of prescription of internal therapy, tongkyutang, bangpungtongsungsan, shinisan and yeotaektongkitang are often used. In the frequency of herb of internal therapy, baekgi(白芷), bangpung(防風), kanghwal(羌活), chungung(川芎) and seuma(升麻) are often used. In the frequency of prescription of external therapy, changposan is often used. In the frequency of herb of external therapy, sesin(細辛), tongcho(通草), chungung(川芎), buza(附子) and koache(瓜薺) are often used. 2. Watery Rhinorrhea : In the frequency of prescription of internal therapy, tongkyutang, seshinsan and chunchosan are often used. In the frequency of herb of internal therapy, chungung(川芎), seshin(細辛) and bangpung(防風) are often used. In the frequency of prescription of external therapy, seshingo is often used. In the frequency of herb of external therapy, seshin(細辛), chuncho(川椒) and bangpung(防風) are often used. 3. Viscous Rhinorrhea : In the frequency of prescription of internal therapy, bangpungtang, changisan and shinisan are often used. In the frequency of herb of internal therapy, chungung(川芎), bangpung(防風), bakha(薄荷) and hwangeum(黃芩) are often used. 4. Anosmia : In the frequency of prescription of internal therapy, yeotaektongkitang is often used. In the frequency of herb of internal therapy, bangpung(防風), baegi(白芷) and kangwhal(羌活) are often used. 5. Nasal Polyp: In the frequency of prescription of internal therapy, yangpesan is often used. In the frequency of herb of internal therapy, baekchul(白朮), kunkang(乾薑) and hwangkeum(黃芩) are often used. In the frequency of prescription of external therapy, shinigo, tongchosan and baekhwangsan are often used. In the frequency of herb of external therapy, seshin(細辛), koache(瓜薺) and woonghwang(雄黃) are often used. 6. Epistaxis : In the frequency of prescription of internal therapy, sanggihwangtang is often used. In the frequency of herb of internal therapy, sanggihwang(生地黃), hwanggeum(黃芩) and jakyak(芍藥) are often used. 7. Rhinophyma : In the frequency of prescription of internal therapy, hyunggasan and chunghyulsamultang are often used. In the frequency of herb of internal therapy, danggui(當歸), hwanggeum(黃芩) and chija(梔子) are often used. In the frequency of prescription of external therapy, baekbansan is often used. In the frequency of herb of external therapy, yoohwang(硫黃), kyungbun(輕粉) and hangin(杏仁) are often used.

  • PDF

작약의 종(種), 부위 및 생육시기에 따른 성분 함량의 변화 (Change of Medicinal Components by Different Species, Plant Parts and Growth Stage of Paeonia spp.)

  • 김세종;박준홍;김길웅
    • 한국작물학회지
    • /
    • 제51권3호
    • /
    • pp.215-219
    • /
    • 2006
  • 작약의 이용성을 높이기 위해 작약의 종 및 품종, 생육시기, 식물체 부위별 성분의 함량 분포와 변화를 HPLC를 이 용하여 분석한 결과를 요약하면 다음과 같다. 작약의 종 및 품종간 성분의 함량 분포는 야생작약(P. japonica M., P. obovata M., P. anomala L.) 보다는 재배작약(태백작약, 의성작약)에서 전반적으로 함량이 더 높았고, 성분별 분포는 paeonifloin, methyl gallate, astragalin, kaempferol 순으로 높았으며 methyl gallate 는 의성작약에서 0.45%로 가장 높았다. 식물체 부위별 함량 분포는 methyl gallate는 꽃잎에서 1.79%로 가장 높았으며 잎에는 0.56% 함유하였고, 뿌리에는 0.01%로서 소량 분포하였다. Astragalin 은 꽃잎과 잎에서 높았고, 작약의 지표 성분인 paeoniflorin 은 뿌리에서 2.52%로 가장 높았으며 잎에도 1.09%나 함유하여 이용 가치가 매우 높다고 사료된다. 생육시기별 함량 분포는 생육초기인 4월에 가장 높았고 생육 후기로 갈수록 감소하는 경향이므로 잎과 줄기를 이용하려면 뿌리 수확직전인 $8{\sim}9$월이 적기라고 생각된다.

Effects of Danggi-Jakyak-San on Antiplatelet and Antihemolysis Activity of in Human blood

  • Sa, Eun-Ho;Son, Soo-Gon;Park, Won-Hwan
    • 동의생리병리학회지
    • /
    • 제20권2호
    • /
    • pp.460-466
    • /
    • 2006
  • We wondered whether the mechanisms of antiplatelet aggregation of DJS-WE were through multiple pathways. Danggijakyak-san(DJS) consisting of 6 herbes of Paeoniae Radix, Poria Cocos, Angelicae Sinensis Radix, Cnidii Rhizoma, Atractylodis Macrocephalae Rhizoma and Alismatis Rhizoma, is a crude mixture of a commonly used Korean herbal medicine. The water extract (DJS-WE) of DJS has been known to have an anti-platelet aggregation activity. We have reported that DJS-WE inhibited ADP-induced aggregation as well as arachidonic acid-induced aggregation of human platelet. Clinical studies on the cardiovascular effects of DJS-WE have been done in Korea. The DJS has been used as a remedy for gastrointestinal disorders (abdominal pain, dysentery), headache, amenorrhea, and postpartum hemorrhage. It has also been claimed to have a remarkable central stimulant effect, a transient hypertensive effect, and positive inotropic and chronotropic effects. In this paper, we evaluated the possible mechanisms of the antiplatelet activity of DJS-WE using human platelets. On the other hand, the role of DJS-ethanol extract on the inhibition of platelet aggregation and hemolytic effect have not yet been investigated in detail. We also used the method of activated partial thromboplastin times (APTT) for the first time to study the inhibition on platelet aggregation activity of DJS-ethanol extract. The effect of DJS-WE on hemolysis was also investigated. DJS-WE showed a high hemolysis ability on human blood.

작약탕(芍藥湯) 물 추출물의 항염증작용에 관한 연구 (Study on the Anti-inflammatory Effect of Jakyak-tang Water Extract)

  • 서윤희;강옥화;권동렬;이장석;한종현;이기남;정명수
    • 동의생리병리학회지
    • /
    • 제25권3호
    • /
    • pp.503-509
    • /
    • 2011
  • Jakyaktang(芍藥湯; JYT) exhibits potent anti-inflammatory activity in widely intestinal disease, but its mechanism was undisclosed. To elucidate the molecular mechanisms of JYT on pharmacological and biochemical actions in inflammation, we examined the effect of JYT on pro-inflammatory mediators in phorbol 12-myristate 13-acetate (PMA) plus A23187-induced mast cell and lipopolysaccharide (LPS)-stimulated macrophages. The investigation focused on whether JYT inhibited pro-inflammatory cytokines such as interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) in PMA plus A23187- induced HMC-1 cells and inflammatory madiators such as nitric oxide (NO), TNF-${\alpha}$, IL-6, iNOS, COX-2 in LPS-stimulated RAW 264.7 cells. We found that JYT inhibited LPS-induced NO, TNF-${\alpha}$ and IL-6 productions as well as the expressions of iNOS and COX-2. These results suggest that JYT has inhibitory effects on mast cell-mediated and macropage-mediated inflammation.

A Study on Single Dose Toxicity of Mecasin Pharmacopuncture Injection in Muscle

  • Cha, Eunhye;Jeong, Hohyun;Lee, Jongchul;Lee, Seongjin;Park, Manyong;Kim, Sungchul
    • 대한한의학회지
    • /
    • 제36권2호
    • /
    • pp.36-42
    • /
    • 2015
  • Objectives: This study was carried out to analyze the single dose toxicity of Mecasin(Gami-Jakyak Gamcho buja Decoction) pharmacopuncture in muscle of Sprague-Dawley rats. Methods: All experiments were performed at the Medvill, an institution acknowledged to conduct non-clinical studies, under the Good Laboratory Practice (GLP) regulations. Sprague-Dawley rats were chosen in this pilot study. The reason Sprague-Dawley rats were chosen is that they have been widely used in safety test in the field of medicine, so the results can be easily compared with many other databases. Doses of Mecasin pharmacopuncture, 0, 500, 1,000, and 2,000mg/kg, were registered to the experimental groups, and a dose of normal saline solution, 10 ml/kg, was registered to the control group. Mecasin pharmacopuncture and normal saline were injected into the thigh of the rats by disposable syringes at intervals of six hours twice a day. This study was performed under the approval of the Institutional Animal Ethic Committee. Results: There is no death or abnormality in any of the four groups. No significant changes in weight, hematological parameters or clinical chemistry between the control group and the experimental groups were observed. To inspect abnormalities in organs and tissues, we used microscopy to examine representative histological sections of each specified organ; the results showed no significant differences in any of the organs or tissues. Conclusion: The above outcomes suggest that treatment with Mecasin pharmacopuncture is relatively safe. Further evaluations and studies on this subject are needed to prove more concrete evidence.

인화귀원(引火歸原)의 병기론 연구 (Pathological Mechanistic Study of Conducting Fire Back to Its Origin)

  • 조원준;김영목
    • 동의생리병리학회지
    • /
    • 제21권4호
    • /
    • pp.795-802
    • /
    • 2007
  • The fire not to back to its origin(火不歸原) is said that source yang(元陽) of sea of qi(氣海) rises because fire(火) of lower energizer(下焦) can't return to its origin. Successive medical men regarded the cause of it as yang deficiency(陽虛) or yin deficiency(陰虛) generally, but Jangseoksun(張錫純) presented eight kinds of cause, they are syndrome of upcast yang(戴陽證), deficiency of qi(氣虛), yin deficiency, yin and yang deficiency(陰陽虛), thoroughfare qi ascending counterflow(衝氣上衝), heart fire(心火), yang deficiency with cold fluid retention(寒飮) in middle energizer(中焦寒飮), yang deficiency with sunken cold locked in(沈寒錮冷). The method of conducting fire back to its origin may be the treatment of fire not to back to its origin as an interpretation of the phrase in a broad sense, but it is limited to yang deficiency with sunken cold locked in besides syndrome of upcast yang as the treatment based on pathological conditions. By this standpoint Eunsuryong(殷壽龍) used conducting fire back to its origin to remove hidden cold(伏寒) and make rising false fire(假火) settle. The meaning of conducting fire back to its origin is not just raise yang qi(陽氣) but break sunken cold locked in by using the drugs like Buja(附子), Yukgye(肉桂). Jakyak(芍藥) can concentrate yang qi on the life gate(命門) by converging it, Sukjihwang(熟地黃) can supply yin essence(陰精) and check the intense nature of tonifing yang(補陽) drugs. So if we want to use the method of conducting fire back to its origin, we should confirm the symptoms of sunken cold locked in and yang deficiency not to misdiagnose yin deficiency.

전신 강직-근간대성 발작을 호소하는 약물 난치성 뇌전증 환자에 대한 한의 치험 1례 (A Case Report of a Drug-resistant Epilepsy Patient Complaining Generalized Tonic-Clonic Seizures Treated with Korean Medical Treatment)

  • 이영선;정성훈;배인후;조기호;문상관;정우상;권승원
    • 대한한방내과학회지
    • /
    • 제43권3호
    • /
    • pp.460-468
    • /
    • 2022
  • Objective: In this case report, we address the case of a 22-year-old man complaining of generalized tonic-clonic seizures due to drug-resistant epilepsy. Methods: A patient was treated with Korean medicine, including herbal medication, Shihogyeji-tang (SGT), and acupuncture. We evaluated improvements in symptoms using the Korean version of the Epilepsy Self-Efficacy Scale and quality of life. Results: After 37 days of Korean medicine treatment, there were improvements in the patient's quality of life and self-efficacy in seizure control. Conclusions: This case report suggests that SGT and acupuncture might be effective in drug-resistant epilepsy via action on neurons. SGT showed excellent tolerability for drug-resistant epilepsy patients. Our experience provides evidence that SGT and acupunctue may be used as alternative treatment options when antiepileptic drugs do not work in epilepsy patients.